Trials / Conditions / Newly Diagnosed Multiple Myeloma (NDMM)
Newly Diagnosed Multiple Myeloma (NDMM)
6 registered clinical trials studyying Newly Diagnosed Multiple Myeloma (NDMM) — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligibl NCT07247097 | Massachusetts General Hospital | Phase 2 |
| Not Yet Recruiting | RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma NCT07114432 | Tianjin Medical University Cancer Institute and Hospital | Phase 1 |
| Recruiting | Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients NCT07296627 | Peking University People's Hospital | — |
| Recruiting | 18F-Fluciclovine PET/CT in Multiple Myeloma NCT06103838 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in NCT07087964 | Universiteit Antwerpen | — |
| Active Not Recruiting | Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM NCT04653246 | Jacob Laubach, MD | Phase 2 |